Decompensated Cirrhosis clinical trials

Explore recruiting decompensated cirrhosis clinical trials.

Recruiting decompensated cirrhosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Decompensated Cirrhosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and efficacy of a human albumin solution with restored structural profile in patients with decompensated cirrhosis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

LIVER AKI: A randomized, open-label trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with decompensated cirrhosis and AKI 1B or grater.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Fecal Microbiome Transplantation in Cirrhosis. Randomized, Double-blinded, Placebo-Controlled trial in patients with decompensated cirrhosis.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital Mortality

France, Germany, Belgium, Spain, Italy, Austria +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Norfloxacin for amelioration of portal hypertension in decompensated cirrhosis - a randomized, placebo-controlled, double-blinded clinical trial

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy versus Bulevirtide in Participants with Chronic HDV Infection (ECLIPSE 3)

Bulgaria, Italy, Netherlands, Germany, Belgium, Spain +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Decompensated Cirrhosis trials by city

Decompensated Cirrhosis in Toronto Decompensated Cirrhosis in Vancouver Decompensated Cirrhosis in Montreal Decompensated Cirrhosis in Calgary Decompensated Cirrhosis in Edmonton Decompensated Cirrhosis in Ottawa Decompensated Cirrhosis in Winnipeg Decompensated Cirrhosis in Quebec City Decompensated Cirrhosis in Hamilton Decompensated Cirrhosis in Kitchener Decompensated Cirrhosis in London Decompensated Cirrhosis in Halifax Decompensated Cirrhosis in New York Decompensated Cirrhosis in Los Angeles Decompensated Cirrhosis in Chicago Decompensated Cirrhosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease